B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 4 610 KRW 1.32% Market Closed
Market Cap: 262.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

BioPlus Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioPlus Co Ltd
Cash Equivalents Peer Comparison

Comparables:
137310
E
294090
T
340570
H
205470
I
119610

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
BioPlus Co Ltd
KOSDAQ:099430
Cash Equivalents
â‚©46B
CAGR 3-Years
42%
CAGR 5-Years
68%
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Cash Equivalents
â‚©482.4B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
EOFlow Co Ltd
KOSDAQ:294090
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
T&L Co Ltd
KOSDAQ:340570
Cash Equivalents
â‚©19.3B
CAGR 3-Years
-18%
CAGR 5-Years
47%
CAGR 10-Years
N/A
H
Humasis Co Ltd
KOSDAQ:205470
Cash Equivalents
â‚©11.6B
CAGR 3-Years
-25%
CAGR 5-Years
36%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Cash Equivalents
â‚©10.4B
CAGR 3-Years
-7%
CAGR 5-Years
3%
CAGR 10-Years
17%

See Also

What is BioPlus Co Ltd's Cash Equivalents?
Cash Equivalents
46B KRW

Based on the financial report for Dec 31, 2023, BioPlus Co Ltd's Cash Equivalents amounts to 46B KRW.

What is BioPlus Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
68%

Over the last year, the Cash Equivalents growth was 151%. The average annual Cash Equivalents growth rates for BioPlus Co Ltd have been 42% over the past three years , 68% over the past five years .

Back to Top